09.01.05
Indication: Memory
Source: First Alzheimer’s Association International Conference on Prevention of Dementia, Washington, D.C.
Research: Seventy subjects, aged 65 and older, who had mild cognitive impairment, were randomly assigned to receive four GETO capsules and two placebo pills, two piracetam pills (a psychoactive drug) and four placebo pills, or six placebo pills three times a day for three months.
Results: After three months of treatment, mental function scores improved equally with GETO and piracetam. The patients then stopped taking any treatment. One year after the start of the study, mental functions scores had decreased in the GETO group, but they were still higher than those that had taken only placebo. In addition, the study showed that the total score for five memory items was higher in the GETO group than both the piracetam and placebo group at the one year point.
Source: First Alzheimer’s Association International Conference on Prevention of Dementia, Washington, D.C.
Research: Seventy subjects, aged 65 and older, who had mild cognitive impairment, were randomly assigned to receive four GETO capsules and two placebo pills, two piracetam pills (a psychoactive drug) and four placebo pills, or six placebo pills three times a day for three months.
Results: After three months of treatment, mental function scores improved equally with GETO and piracetam. The patients then stopped taking any treatment. One year after the start of the study, mental functions scores had decreased in the GETO group, but they were still higher than those that had taken only placebo. In addition, the study showed that the total score for five memory items was higher in the GETO group than both the piracetam and placebo group at the one year point.